Brad Pitt and Tom Cruise in an epic battle on top of a building. A lion and a wildebeest calf napping together. How many of us have been caught up scrolling through social media and captured by one almost-too-much-to-believe story or another?
Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA
This past year has been marked with substantial change, not only in health care and pharmacy, but in just about every aspect of our lives.
In the past several months, at least one prominent physician organization seems to have pumped up its rhetoric regarding pharmacists.
Recently, APhA issued a press release and social media regarding a congressional win for the profession that allows pharmacists to be recognized by DEA—if permitted by their state—as prescribers for buprenorphine.
By the time you are reading this month’s column, states will have submitted their responses to HHS’s request for proposals (RFP) in support of the Rural Health Transformation Program.